# Bio-Techne to Present at the Bank of America Securities 2026 Global Healthcare Conference
Canonical URL: https://biopharmsignal.com/news/TECH/bio-techne-to-present-at-the-bank-of-america-securities-2026-global-healthcare-conference
Ticker: TECH
Company: Bio-Techne
Source: Bio-Techne
Published: 2026-05-04 11:00 EST
Original Source URL: https://investors.bio-techne.com
## Summary

<div class="xn-content"> <p><span class="legendSpanClass">MINNEAPOLIS</span>, <span class="legendSpanClass">May 4, 2026</span> /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the Bank of America Securities 2026 Global Healt

## Article Body
MINNEAPOLIS, May 4, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the Bank of America Securities 2026 Global Healthcare Conference on Tuesday, May 12, 2026, at 9:20 a.m. PDT. A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.

About Bio-Techne
Bio‑Techne Corporation (NASDAQ: TECH) is a global life sciences company headquartered in Minnesota, celebrating 50 years of empowering scientific and diagnostic communities to reach better answers. The company provides high‑quality reagents, analytical instruments, and precision diagnostics. Its portfolio is organized into three customer‑focused brands: R&D Systems™, Bio‑Techne Spatial™, and Bio‑Techne Diagnostics™, reflecting the scientific journey from discovery to translational research to clinical decision‑making. Bio‑Techne operates in 34 locations worldwide and employs approximately 3,100 people. In fiscal year 2025, the company generated over $1.2 billion in net sales. Its more than 500,000 products are used globally by academic researchers, biopharmaceutical and biotechnology companies, and clinical diagnostic laboratories.

For more information on Bio-Techne and its brands, please visit www.bio-techne.com or follow the company on social media at LinkedIn, X, or YouTube.

Contact:

David Clair, Vice President, Investor Relations

david.clair@bio-techne.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-the-bank-of-america-securities-2026-global-healthcare-conference-302760526.html

SOURCE Bio-Techne Corporation
## Recent Company News
- 2026-07-08 10:30 EST — [Bio-Techne Launches Expanded R&D Systems AI-Engineered Designer Protein Portfolio](https://biopharmsignal.com/news/TECH/bio-techne-launches-expanded-r-d-systems-ai-engineered-designer-protein-portfoli-21b908e1) — Source: Bio-Techne
- 2026-06-25 10:10 EST — [Merck KGaA, Darmstadt, Germany, Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sciences Markets](https://biopharmsignal.com/news/TECH/merck-kgaa-darmstadt-germany-agrees-to-acquire-bio-techne-strengthening-leadersh-50e2ac1c) — Source: Bio-Techne
- 2026-06-04 10:30 EST — [Bio‑Techne and Refeyn Close Critical Gap in Bispecific Antibody and Biosimilar Characterization](https://biopharmsignal.com/news/TECH/bio-techne-and-refeyn-close-critical-gap-in-bispecific-antibody-and-biosimilar-characterization) — Source: Bio-Techne
- 2026-05-06 10:30 EST — [Bio-Techne Declares Dividend](https://biopharmsignal.com/news/TECH/bio-techne-declares-dividend) — Source: Bio-Techne
- 2026-05-06 10:30 EST — [Bio-Techne Releases Third Quarter Fiscal 2026 Results](https://biopharmsignal.com/news/TECH/bio-techne-releases-third-quarter-fiscal-2026-results) — Source: Bio-Techne
## Related News
- 2026-07-21 20:15 EST — BFRG — [BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026](https://biopharmsignal.com/news/BFRG/bullfrog-ai-to-participate-in-water-tower-research-fireside-chat-on-thursday-jul-78357ce8)
- 2026-07-21 20:05 EST — CLPT — [ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026](https://biopharmsignal.com/news/CLPT/clearpoint-neuro-to-announce-second-quarter-2026-results-august-3-2026-6e4f3c05)
- 2026-07-21 20:05 EST — TCMD — [Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026](https://biopharmsignal.com/news/TCMD/tactile-medical-to-release-second-quarter-of-fiscal-year-2026-financial-results--798d4004)
- 2026-07-21 20:05 EST — PIII — [P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call](https://biopharmsignal.com/news/PIII/p3-health-partners-schedules-second-quarter-2026-earnings-release-and-conference-6c9bd8a7)
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)